Embodiments of the present invention relate generally to the field of medical devices, and specifically to percutaneous devices for treatment of a subject.
Some medical conditions are treated by implanting a shunt between two body cavities, typically to release excess pressure from one of the cavities into the other. For example, a shunt may be implanted between the right and left atria of the heart for the treatment of pulmonary hypertension by decompression of the right atrium, or for the treatment of congestive heart failure by decompression of the left atrium. Implantable shunts of this sort are described, for example, in U.S. Pat. No. 8,091,556, whose disclosure is incorporated herein by reference.
U.S. Pat. No. 9,067,050, whose disclosure is incorporated herein by reference, describes an arteriovenous shunt assembly including a shunt and a pull wire operated flow control mechanism. The shunt has a tubular body that defines a fluid passageway between a first end and a second end thereof. The pull wire mechanism includes a portion disposed around the tubular shunt in at least one loop. The at least one loop may be selectively tightened or loosened remotely from the shunt to regulate the rate of blood flow through the tubular shunt.
US Patent Application Publication 2014/0303710, whose disclosure is incorporated herein by reference, describes a recyclable and adjustable interventional stent for intravascular constriction. The stent main body is divided into three parts and shaped like a waist drum with expansion parts being arranged on the upper and lower parts of the stent main body respectively for supporting and positioning. A variable aperture part is arranged in the middle of the stent main body. The upper expansion part is or is not provided with a coating; the middle variable aperture part and the upper half part of the lower expansion part are covered with a pericardium subjected to anti-calcification treatment; and a metal wire ring is passed through the lowermost edge of the stent. A compound conveying guide pipe is composed of an outer sheath and a core. The core is a hollow pipe and a wire hanging groove is arranged on the outer side wall of the tip of the pipe to hang the metal wire ring of the lowermost edge of the stent. A fixing bolt on the outer sheath is used for fixing the relative position between the outer sheath and the core. The stent is used to replace conventional pulmonary artery banding as, adhesion not being formed around the heart and major vessels and pulmonary stenosis not being formed, difficulties during radical surgery are not increased.
US Patent Publication 2013/0178784, whose disclosure is incorporated herein by reference, describes devices and methods for treating heart disease by normalizing elevated blood pressure in the left and right atria of a heart of a mammal. Devices may include an adjustable hydraulic diameter shunt portion which can be manually adjusted in vivo. Methods are provided for adjusting the flow rate of the devices in vivo.
U.S. Pat. No. 5,035,706, whose disclosure is incorporated herein by reference, describes a self-expanding stent formed of stainless steel wire arranged in a closed zig-zag configuration. The stent includes an endless series of straight sections joined at their ends by bends. The stent is compressible into a reduced diameter size for insertion into and removal from a body passageway. The bends of at least one end of the stent are formed into eyes for connection with the eyes at one end of a similarly constructed stent to permit single-step introduction of several lengths of stent into the passageway. A stent can include a monofilament thread passing through successive eyes at one end of the stent, the thread passing through each eye at least once and through some of the eyes a second time. The trailing ends of the thread extend from the stent and outside the body passageway. The stent can be retrieved from the body passageway by threading a tube of the free ends of the thread until the tube is adjacent the stent. The diameter at one end of the stent is reduced by pulling the free ends of the thread through the tube. A sheath concentrically disposed over the tube is introduced into the body passageway and over the remaining length of the stent to further compress the stent for removal from the passageway.
U.S. Pat. No. 6,221,096, whose disclosure is incorporated herein by reference, describes an intravascular stent having an elastic self-expandable cylindrical stent proper. The stent proper is connected to metal support wires that are long enough to reach outside of the body of a patient through a catheter. Manipulation of the support wires pushes the stent proper into a blood vessel from within the catheter, thereby allowing it to expand there, and then contracts and retracts the stent proper into the catheter, repeatedly.
U.S. Pat. No. 6,468,303, whose disclose is incorporated herein by reference, describes a collapsible medical device and associated method for shunting selected organs and vessels, wherein the medical device is shaped from a shape memory metal fabric. The device may be used, for example, to non-surgically create a transjugular intrahepatic portosystemic shunt. The device is preferably made from a continuous tubular metal fabric and includes two outer flanges that reduce device migration and includes a central passageway between the two outer flanges. The metal fabric may be heat treated within a mold in order to substantially set a desired relaxed shape of the device. The medical device includes a fastener for attaching to the end of a guide wire or delivery catheter. The medical device having the desired relaxed shape may be collapsed and delivered through a catheter or the like for deployment in a desired channel or opening in a patient's body and is retrievable after deployment.
An implanted interatrial shunt may cause various complications, such as distortion of the interatrial septum, cardiac arrhythmias, inability to use the transseptal approach for future interventions, paradoxical embolism, and/or blood desaturation. Hence, for cases in which an interatrial shunt is required only temporarily (i.e., for a short period of time, such as less than one week), an implanted shunt may not necessarily be the most appropriate solution for treatment.
Embodiments of the present invention therefore provide—as an alternative to an implanted shunt—shunting apparatus that may be placed within the subject for only a short period of time, e.g., for less than one week, or even less than one day (e.g., 2-3 hours, 3-6 hours, or 6-12 hours). The apparatus comprises a shunt, along with one or more wires that extend from the proximal portion of the shunt to the exterior of the subject. These wires, which are typically controlled via a control handle, may be used to collapse the shunt, whenever the shunt is no longer needed. Following the collapse of the shunt, the shunt may be easily withdrawn from the subject.
In some embodiments, another wire, which passes circumferentially along the intermediate portion of the shunt and also extends to the exterior of the subject, may be used to adjust the diameter of the shunt while the shunt is inside the subject, thus regulating the flow of blood across the interatrial septum.
Other temporary shunts described herein include a shunt that is coupled to a distal end of a sheath. The shunt is advanced, in a collapsed state, over a guidewire, until the shunt spans the interatrial septum. Subsequently, the guidewire is retracted while the sheath is held in place, such that a stopper coupled to the distal portion of the guidewire applies a longitudinally compressive force to the shunt, thus causing the shunt to open. The sheath is then locked with respect to the guidewire, such that the shunt remains open. Upon the conclusion of treatment, the sheath is unlocked, such that the shunt collapses, and subsequently, the shunt is removed from the subject.
(In general, within the context of medical applications, the term “shunt” may refer to (i) a passage that diverts a bodily fluid from one portion of the body to another, or (ii) a device that is used to establish, and/or maintain, such a passage. In the context of the present application, including the claims, the term “shunt” typically refers to the latter.)
There is therefore provided, in accordance with some embodiments of the present invention, apparatus that includes a shunt. The shunt includes a flared distal portion, a flared proximal portion, and an intermediate portion, disposed between the distal portion and the proximal portion. The apparatus further includes a constricting flexible longitudinal element passing circumferentially along the intermediate portion of the shunt, configured to constrict the intermediate portion of the shunt, and one or more proximal-portion-collapsing flexible longitudinal elements configured to collapse the proximal portion of the shunt.
In some embodiments, the constricting flexible longitudinal element includes a wire.
In some embodiments, the intermediate portion of the shunt is shaped to define a plurality of orifices, and the wire passes circumferentially along the intermediate portion by passing through the orifices.
In some embodiments, the proximal portion of the shunt is shaped to define a plurality of orifices, and the proximal-portion-collapsing flexible longitudinal elements include one or more wires, each of which passes through at least two of the orifices.
There is further provided, in accordance with some embodiments of the present invention, a method that includes placing a shunt between two chambers of a heart of a subject, such that one or more shunt-collapsing flexible longitudinal elements extend from a proximal portion of the shunt to an exterior of the subject. The method further includes, subsequently, using the shunt-collapsing flexible longitudinal elements, collapsing the shunt into a catheter.
In some embodiments, the method further includes, using the catheter, removing the shunt from the subject.
In some embodiments, removing the shunt from the subject includes removing the shunt from the subject after less than one week from the placement of the shunt.
In some embodiments, the two chambers of the heart are two atria of the heart.
In some embodiments, the two chambers of the heart are two ventricles of the heart.
In some embodiments, the method further includes, while the shunt is between the two chambers of the heart, constricting the shunt, using a constricting flexible longitudinal element that extends from the shunt to the exterior of the subject.
There is further provided, in accordance with some embodiments of the present invention, a method that includes placing a shunt between two atria of a subject, and, after less than one week from the placement of the shunt, withdrawing the shunt from the subject.
There is further provided, in accordance with some embodiments of the present invention, apparatus that includes a sheath, and a shunt coupled to a distal end of the sheath, the shunt being configured to open from a collapsed state to an open state upon a longitudinally compressive force being applied to the shunt.
In some embodiments, the shunt includes a plurality of wires, distal ends of which are joined together, and proximal ends of which are coupled to the sheath.
In some embodiments, the shunt is configured to open by the wires expanding radially outward from each other.
In some embodiments, in the open state, a proximal portion of the shunt and a distal portion of the shunt are wider than an intermediate portion of the shunt that is between the proximal portion of the shunt and the distal portion of the shunt.
In some embodiments, the apparatus further includes:
In some embodiments, the shunt is shaped to define a distal aperture configured to fittingly receive the stopper.
In some embodiments, the stopper includes a bead.
There is further provided, in accordance with some embodiments of the present invention, a method that includes passing a guidewire across a septum that separates between a first chamber of a heart of a subject and a second chamber of the heart, such that a stopper coupled to the guidewire is in the second chamber. The method further includes, subsequently, passing a shunt, in a collapsed state, over the guidewire, until a proximal portion of the shunt is in the first chamber, and a distal portion of the shunt is in the second chamber, and subsequently, using the stopper, opening the shunt from the collapsed state to an open state.
In some embodiments, opening the shunt includes opening the shunt by, using the stopper, pressing against the distal portion of the shunt.
In some embodiments, the shunt is shaped to define a distal aperture, and pressing against the distal portion of the shunt includes pressing against the distal portion of the shunt while the stopper is fittingly received by the distal aperture.
In some embodiments, the first chamber is a right atrium, and the second chamber is a left atrium.
In some embodiments, the first chamber is a right ventricle, and the second chamber is a left ventricle.
In some embodiments, the shunt is coupled to a distal end of a sheath, and the method further includes, subsequently to opening the shunt, maintaining the open state of the shunt by locking the sheath with respect to the guidewire.
In some embodiments, the method further includes:
In some embodiments, removing the shunt from the subject includes removing the shunt from the subject after less than one week from the opening of the shunt.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Reference is initially made to
Apparatus 28 comprises a shunt 26, which may be placed between two chambers of the heart 22 of subject 20, such as within the interatrial septum 24 of heart 22, between the right atrium 30 and the left atrium 32. Alternatively, the shunt may be placed between the two ventricles of the heart, or between any other two body cavities. Shunt 26 typically comprises a flared distal portion 40, a flared proximal portion 44, and an intermediate portion 42, which is disposed between distal portion 40 and proximal portion 44. Distal portion 40 and proximal portion 44 anchor the shunt to septum 24 (i.e., prevent migration of the shunt from within the septum), while intermediate portion 42 provides a passageway across the septum, through which blood may flow. Typically, shunt 26 comprises a shape-memory material, such as Nitinol, such that the shunt expands to its natural shape (the shape shown in
In the context of the present application, including the claims, the proximal and distal portions of the shunt are “flared,” in that these portions extend radially outward from the intermediate portion of the stent. In some embodiments, as shown, each of the proximal and distal portions of the shunt comprises a plurality of leaves 25, such as, for example, six leaves 25, as shown. In other embodiments, the proximal portion and/or the distal portion does not comprise a plurality of leaves, but rather, is shaped to define a flared ring, or has some other suitable form.
To facilitate removal of the shunt, embodiments described herein provide one or more shunt-collapsing flexible longitudinal elements, which extend from proximal portion 44 to the exterior of the subject. For example, as shown in the figures, the shunt-collapsing flexible longitudinal elements may comprise wires 36. Typically, while inside the subject, wires 36 are contained within a lumen 37 of a sheath 31 passing between proximal portion 44 and the exterior of the subject. (For example, sheath 31 may exit the subject via a femoral vein of the subject.) As further described below with reference to
Typically, wires 36 remain coupled to the shunt throughout the time that the shunt is in place inside the subject. Due to wires 36 remaining coupled to the shunt, the shunt may be easily removed immediately upon receiving indication that further shunting is no longer required. In this respect, embodiments described herein differ from other, hypothetical shunting applications in which (i) the shunt is removed only in the event of a complication, and (ii) to remove the shunt, it is necessary to use a lasso or other specialized shunt-removal instrument.
Alternatively to the embodiment shown, a single wire 36 may form a loop that passes through all of the orifices, this single wire controlling the collapse of the entire proximal portion. (In other words, by pulling on the two ends of this single wire, the entire proximal portion may be collapsed.) In yet other embodiments, wires 36 do not form loops; rather, a separate wire is coupled to each leaf. For example, each leaf may be coupled to the distal end of a respective wire. (Thus, for example, a shunt having six proximal leaves is coupled to six wires, one wire per leaf.) Similarly, wires 36 may be formed as extensions of the leaves, such that each leaf has a wire extension that extends to the exterior of the subject. In such embodiments, the proximal portion of the shunt may be collapsed by pulling on the single proximal end of each of the wires.
In some cases, it may be beneficial to adjust the diameter of intermediate portion 42 while the shunt is inside the subject. Hence, apparatus 28 typically further comprises a constricting flexible longitudinal element that passes circumferentially along intermediate portion 42, and extends from the intermediate portion of the shunt to the exterior of the subject. For example, as shown, the constricting flexible longitudinal element may comprise a wire 38 that loops around the intermediate portion of the shunt, both ends of the wire passing through the vasculature of the subject (e.g., within lumen 37, or within a separate lumen 39 of sheath 31), exiting from the subject (e.g., via a femoral vein), and being coupled to control handle 34. The constricting flexible longitudinal element is configured to constrict the intermediate portion of the shunt, by exerting an inward radial force on the intermediate portion of the shunt. For example, to constrict the intermediate portion, and thus reduce the flow of blood across the septum, the control handle may be used to pull both ends of wire 38. (Subsequently, the control handle may be used to hold wire 38 in place, to prevent the intermediate portion from re-expanding.) Conversely, to widen the intermediate portion, the control handle may be used to release wire 38, thus allowing the intermediate portion to expand radially outward.
In some embodiments, as shown, the intermediate portion is shaped to define a plurality of orifices 50, and the wire passes circumferentially along the intermediate portion by passing through the orifices. Alternatively or additionally to comprising a wire, the constricting flexible longitudinal element may comprise a band, strap, ribbon, or any other suitable type of longitudinal element.
In some embodiments, the adjustment of the diameter of the shunt is based on pressure monitoring. For example, as further described below, pressure sensors disposed on the shunt may be used to acquire intra-atrial pressure measurements, and the diameter of the shunt may be adjusted in response to such measurements. Alternatively or additionally, the diameter of the shunt may be adjusted in response to hemodynamic monitoring, such as by the application of flow imaging techniques such as pulsed wave (PW) or continuous wave (CW) Doppler echocardiography.
Typically, to place the shunt within the septum, the shunt is first collapsed and placed inside a delivery catheter 46. Subsequently, catheter 46 is percutaneously inserted into the vasculature of the subject, such as via a femoral vein of the subject, and is then passed through the vasculature into right atrium 30, e.g., via the inferior vena cava. (Alternatively, catheter 46 may be passed into the right atrium via the jugular vein and superior vena cava.) Subsequently, the distal end of the catheter is passed through the septum and into left atrium 32, such that the distal and proximal portions of the shunt are on opposite sides of the septum. (As is known in the art, prior to passing the distal end of the catheter through the septum, a puncturing element may be used to create an opening in the septum, and, optionally, a dilator may be used to enlarge the opening, such that the distal end of the catheter may easily pass through the septum.) The catheter is then withdrawn from over the shunt while the shunt is held in place. As the catheter is withdrawn from over the shunt, the shunt reassumes its natural, non-collapsed shape, such that distal portion 40 opens on the left-atrium side of the septum, and proximal portion 44 opens on the right-atrium side of the septum.
Following the deployment of the shunt, the catheter is withdrawn from the subject, leaving behind the shunt, along with the shunt-collapsing flexible longitudinal elements and the constricting flexible longitudinal element. Alternatively, the catheter may remain within the subject while the shunt is in place. For example, the catheter may remain within the subject such that the distal end of the catheter is near the proximal portion of the shunt. The catheter may thus be used to deliver medication to the shunt site, and/or pressure sensors in the catheter may be used to monitor the intra-atrial pressure.
By way of example,
Shunt 26 helps relieve excess intra-atrial pressure, by allowing blood to flow from the higher-pressure atrium to the lower-pressure atrium. Shunt 26 may thus be used to treat any relevant condition (e.g., pulmonary hypertension or congestive heart failure) for which the relief of excess pressure is beneficial, or, for example, to help prevent left ventricular dilation and remodeling following an acute myocardial insult. Typically, the subject remains hospitalized until the subject's physician decides that sufficient treatment has been provided, at which point the shunt is removed from the subject (as further described immediately below), and the subject is released from hospital. In some embodiments, shunt apparatus 28 comprises one or more pressure sensors, disposed, for example, on shunt 26, on any of the longitudinal elements, and/or in sheath 31. Such pressure sensors may be used to measure (e.g., continuously) the pressure in the subject's right atrium and/or left atrium, in order to monitor progression of the treatment, and ascertain the point in time at which the shunt may be removed from the subject. For example, one pressure sensor may be disposed on the proximal portion of the shunt, and another pressure sensor on the distal portion of the shunt, such that the pressure in both the left atrium and the right atrium is measured.
Reference is now made to
In
In some embodiments, the catheter is advanced while proximal portion 44 is collapsing, such that, as proximal portion 44 continues to collapse, the catheter passes over the shunt, until the distal end of the catheter crosses through the septum and reaches the distal portion of the shunt. (In such embodiments, the state shown in
In some embodiments, two separate tubes run through a single lumen, or two separate lumens, of sheath 31, one of these tubes holding wires 36, and the other of these tubes holding wire 38. Such tubes—which may comprise, for example, HHS® (“Helical Hollow Strand”) Tubes—may provide additional resistance to buckling, such that the pulling force exerted on the wires is effectively transmitted to the shunt. In such embodiments, stopper 52 may be used to prevent the wire-holding tubes from moving proximally as the wires are pulled.
It is noted that the apparatus and methods described above may also be used for applications in which an implanted shunt is required. In such applications, during the implantation procedure, wires 36 may be used to facilitate the retrieval of shunt 26, in the event that the shunt was riot placed at the proper location. Subsequently, upon confirmation that the shunt is properly situated, wires 36 may be detached from shunt 26, and removed from the subject. Similarly, during the implantation procedure, the constricting flexible longitudinal element may be used to adjust the diameter of the shunt. Subsequently, upon completion of the adjustment, the constricting flexible longitudinal element may be locked in place, such as to maintain the diameter of the shunt, and then any proximally-extending portion of the constricting flexible longitudinal element may be detached and removed.
Reference is now made to
Typically, shunt 56 is an expandable structure made from a suitable shape-memory material, such as Nitinol, such that shunt 56 may move from a collapsed state (shown in
As described above with respect to shunt 26, shunt 56 is percutaneously inserted into the subject. First, a guidewire 58 is inserted into the right atrium, e.g., via the femoral vein and the inferior vena cava, as shown. Subsequently, guidewire 58 is passed across septum 24 (from the right atrium to the left atrium), using conventional techniques known in the art, such that the distal portion of the guidewire is in the left atrium. (To introduce guidewire 58, a vascular sheath (not shown), which may alternatively be referred to as a catheter, may be used, as is known in the art. If necessary, a dilating tool may be passed over the guidewire, and through the opening created by the guidewire, to enlarge the opening in the septum.) Subsequently to passing the guidewire across the septum, shunt 56 is passed, in a collapsed state, over the guidewire, until the distal portion of the shunt is in the left atrium, and the proximal portion of the shunt is in the right atrium. In other words, as shown in
A stopper 60 is coupled to the distal portion of guidewire 58 (i.e., near the distal end of the guidewire, such as within one or two millimeters of the distal end). Subsequently to positioning the shunt such that the shunt spans the septum, the stopper is used to open the shunt from the shunt's initial collapsed state. In one embodiment of this technique, the guidewire is retracted (proximally pulled), as indicated by the arrow 70 in the figure, such that the stopper presses against the distal portion of the shunt. While the guidewire is retracted, sheath 62 (and hence, the proximal end of the shunt) is held in place or is advanced, such that, by pressing against the distal portion of the shunt, the stopper applies a longitudinally compressive force to the shunt. The compressive force causes the shunt to open, and hence, the opening in the septum to become enlarged, as shown in
Stopper 60 is referred to herein as a “stopper,” in that stopper 60 stops the advancement of the shunt along the guidewire, by virtue of the stopper being large enough such that the shunt cannot pass over the stopper. Stopper 60 may have any form suitable for applying the longitudinally compressive force to the shunt. For example, the stopper may comprise a bead, as shown in the figure; alternatively, for example, stopper 60 may comprise a plate or rod which, when pressed against the shunt, applies the longitudinally compressive force. In some embodiments, the shunt is shaped to define a distal aperture 66, shaped to fittingly receive the stopper. (In such embodiments, the stopper may be referred to as a “lock,” and distal aperture 66 may be referred to as a “fitting.”) As the guidewire is withdrawn in the proximal direction, the stopper engages with, i.e., is fittingly received by, distal aperture 66. Subsequently, the stopper continues to press against the distal portion of the shunt while the stopper is fittingly received by the distal aperture. The engagement between the distal aperture and the stopper helps the pressing force to be more effectively applied to the shunt.
Typically, to maintain the open state of shunt 56, it is necessary to maintain the longitudinally compressive force on the shunt. This may be accomplished by, using a locking mechanism, locking sheath 62 with respect to (or “against”) the guidewire, i.e., fixing the position of the sheath with respect to the guidewire. For example,
Subsequently, upon completion of the treatment, the sheath is unlocked, e.g., by removing lock 64. The unlocking of the sheath allows the sheath to move proximally, and/or allows the guidewire to move distally, thus removing the longitudinally compressive force that had heretofore been applied to the shunt. The shunt therefore collapses. Subsequently, the sheath, and the shunt, are removed from the subject.
In some embodiments, prior to unlocking the sheath, a catheter is advanced over the sheath, until the distal end of the catheter is near the proximal end of the shunt. Subsequently, upon collapse of the shunt, the shunt is pulled into the catheter, and/or the catheter is advanced over the shunt. The catheter is then used to remove the shunt from the subject. In other embodiments, no catheter is used for removal of the shunt. Rather, upon collapse of the shunt, the sheath and shunt are proximally pulled, through the vasculature of the subject, out of the subject.
In some embodiments, one or more pressure sensors are disposed on guidewire 58, shunt 56, and/or sheath 62. Such pressure sensors may be used to measure the pressure in the subject's right atrium and/or left atrium, as described above for apparatus 28.
Although the description above relates mainly to interatrial shunting, it is noted that shunt 56, and the above-described techniques for deployment thereof, may be used for shunting between any relevant two body cavities. For example, in an interventricular shunting application, guidewire 58 may be passed through the interventricular septum, from the right ventricle to the left ventricle, and the shunt may then be deployed over the guidewire and opened within the interventricular septum.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a divisional application of U.S. application Ser. No. 15/570,752, filed Oct. 31, 2017, now U.S. Pat. No. 10,940,296, which is a national phase of International PCT Patent Application No. PCT/IB2016/52561, filed May 5, 2016, which claims priority from U.S. Provisional Application 62/158,022, entitled “Percutaneous device for temporary stenting and shunting,” filed May 7, 2015, the entire disclosures of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3852334 | Dusza et al. | Dec 1974 | A |
3874388 | King et al. | Apr 1975 | A |
3952334 | Bokros et al. | Apr 1976 | A |
4364395 | Redmond et al. | Dec 1982 | A |
4484955 | Hochstein | Nov 1984 | A |
4601309 | Chang | Jul 1986 | A |
4617932 | Kornberg | Oct 1986 | A |
4662355 | Pieronne et al. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4705507 | Boyles | Nov 1987 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4979955 | Smith | Dec 1990 | A |
4988339 | Vadher | Jan 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5035702 | Taheri | Jul 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5037427 | Harada et al. | Aug 1991 | A |
5089005 | Harada | Feb 1992 | A |
5186431 | Tamari | Feb 1993 | A |
5197978 | Hess | Mar 1993 | A |
5234447 | Kaster et al. | Aug 1993 | A |
5267940 | Moulder | Dec 1993 | A |
5290227 | Pasque | Mar 1994 | A |
5312341 | Turi | May 1994 | A |
5326374 | Ilbawi et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5334217 | Das | Aug 1994 | A |
5378239 | Termin et al. | Jan 1995 | A |
5409019 | Wilk | Apr 1995 | A |
5429144 | Wilk | Jul 1995 | A |
5500015 | Deac | Mar 1996 | A |
5531759 | Kensey et al. | Jul 1996 | A |
5545210 | Hess et al. | Aug 1996 | A |
5556386 | Todd | Sep 1996 | A |
5578008 | Hara | Nov 1996 | A |
5584803 | Stevens et al. | Dec 1996 | A |
5597377 | Aldea | Jan 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5662711 | Douglas | Sep 1997 | A |
5702412 | Popov et al. | Dec 1997 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5741324 | Glastra | Apr 1998 | A |
5749880 | Banas et al. | May 1998 | A |
5779716 | Cano et al. | Jul 1998 | A |
5795307 | Krueger | Aug 1998 | A |
5810836 | Hussein et al. | Sep 1998 | A |
5824062 | Patke et al. | Oct 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5846261 | Kotula et al. | Dec 1998 | A |
5910144 | Hayashi | Jun 1999 | A |
5916193 | Stevens et al. | Jun 1999 | A |
5941850 | Shah et al. | Aug 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5990379 | Gregory | Nov 1999 | A |
6007544 | Kim | Dec 1999 | A |
6027518 | Gaber | Feb 2000 | A |
6039755 | Edwin et al. | Mar 2000 | A |
6039759 | Carpentier et al. | Mar 2000 | A |
6086610 | Duerig et al. | Jul 2000 | A |
6111520 | Allen et al. | Aug 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6124523 | Banas et al. | Sep 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6210318 | Lederman | Apr 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6214039 | Banas et al. | Apr 2001 | B1 |
6217541 | Yu | Apr 2001 | B1 |
6221096 | Aiba et al. | Apr 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6242762 | Brown et al. | Jun 2001 | B1 |
6245099 | Edwin et al. | Jun 2001 | B1 |
6254564 | Wilk et al. | Jul 2001 | B1 |
6260552 | Mortier et al. | Jul 2001 | B1 |
6264684 | Banas et al. | Jul 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6270526 | Cox | Aug 2001 | B1 |
6277078 | Porat et al. | Aug 2001 | B1 |
6278379 | Allen et al. | Aug 2001 | B1 |
6290728 | Phelps et al. | Sep 2001 | B1 |
6302892 | Wilk | Oct 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6328699 | Eigler et al. | Dec 2001 | B1 |
6344022 | Jarvik | Feb 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6391036 | Berg et al. | May 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6406422 | Landesberg | Jun 2002 | B1 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6451051 | Drasler et al. | Sep 2002 | B2 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6468303 | Amplatz et al. | Oct 2002 | B1 |
6475136 | Forsell | Nov 2002 | B1 |
6478776 | Rosenman et al. | Nov 2002 | B1 |
6485507 | Walak et al. | Nov 2002 | B1 |
6488702 | Besselink | Dec 2002 | B1 |
6491705 | Gifford, III et al. | Dec 2002 | B2 |
6527698 | Kung et al. | Mar 2003 | B1 |
6544208 | Ethier et al. | Apr 2003 | B2 |
6547814 | Edwin et al. | Apr 2003 | B2 |
6562066 | Martin | May 2003 | B1 |
6572652 | Shaknovich | Jun 2003 | B2 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6589198 | Soltanpour et al. | Jul 2003 | B1 |
6616675 | Evard et al. | Sep 2003 | B1 |
6632169 | Korakianitis et al. | Oct 2003 | B2 |
6638303 | Campbell | Oct 2003 | B1 |
6641610 | Wolf et al. | Nov 2003 | B2 |
6645220 | Huter et al. | Nov 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6685664 | Levin et al. | Feb 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6740115 | Lombardi et al. | May 2004 | B2 |
6758858 | McCrea et al. | Jul 2004 | B2 |
6764507 | Shanley et al. | Jul 2004 | B2 |
6770087 | Layne et al. | Aug 2004 | B2 |
6797217 | McCrea et al. | Sep 2004 | B2 |
6890350 | Walak | May 2005 | B1 |
6923829 | Boyle et al. | Aug 2005 | B2 |
6970742 | Mann et al. | Nov 2005 | B2 |
7001409 | Amplatz | Feb 2006 | B2 |
7004966 | Edwin et al. | Feb 2006 | B2 |
7025777 | Moore | Apr 2006 | B2 |
7060150 | Banas et al. | Jun 2006 | B2 |
7083640 | Lombardi et al. | Aug 2006 | B2 |
7115095 | Eigler et al. | Oct 2006 | B2 |
7118600 | Dua et al. | Oct 2006 | B2 |
7137953 | Eigler et al. | Nov 2006 | B2 |
7147604 | Allen et al. | Dec 2006 | B1 |
7149587 | Wardle et al. | Dec 2006 | B2 |
7169160 | Middleman et al. | Jan 2007 | B1 |
7169172 | Levine et al. | Jan 2007 | B2 |
7195594 | Eigler et al. | Mar 2007 | B2 |
7208010 | Shanley et al. | Apr 2007 | B2 |
7226558 | Nieman et al. | Jun 2007 | B2 |
7245117 | Joy et al. | Jul 2007 | B1 |
7294115 | Wilk | Nov 2007 | B1 |
7306756 | Edwin et al. | Dec 2007 | B2 |
7402899 | Whiting et al. | Jul 2008 | B1 |
7439723 | Allen et al. | Oct 2008 | B2 |
7468071 | Edwin et al. | Dec 2008 | B2 |
7483743 | Mann et al. | Jan 2009 | B2 |
7498799 | Allen et al. | Mar 2009 | B2 |
7509169 | Eigler et al. | Mar 2009 | B2 |
7550978 | Joy et al. | Jun 2009 | B2 |
7578899 | Edwin et al. | Aug 2009 | B2 |
7590449 | Mann et al. | Sep 2009 | B2 |
7615010 | Najafi et al. | Nov 2009 | B1 |
7621879 | Eigler et al. | Nov 2009 | B2 |
7679355 | Allen et al. | Mar 2010 | B2 |
7717854 | Mann et al. | May 2010 | B2 |
7794473 | Tessmer et al. | Sep 2010 | B2 |
7839153 | Joy et al. | Nov 2010 | B2 |
7842083 | Shanley et al. | Nov 2010 | B2 |
7854172 | O'Brien et al. | Dec 2010 | B2 |
7862513 | Eigler et al. | Jan 2011 | B2 |
7914639 | Layne et al. | Mar 2011 | B2 |
7939000 | Edwin et al. | May 2011 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
7993383 | Hartley et al. | Aug 2011 | B2 |
8012194 | Edwin et al. | Sep 2011 | B2 |
8016877 | Seguin et al. | Sep 2011 | B2 |
8021420 | Dolan | Sep 2011 | B2 |
8025625 | Allen | Sep 2011 | B2 |
8025668 | McCartney | Sep 2011 | B2 |
8043360 | McNamara et al. | Oct 2011 | B2 |
8070708 | Rottenberg et al. | Dec 2011 | B2 |
8091556 | Keren et al. | Jan 2012 | B2 |
8096959 | Stewart et al. | Jan 2012 | B2 |
8137605 | McCrea et al. | Mar 2012 | B2 |
8142363 | Eigler et al. | Mar 2012 | B1 |
8147545 | Avior | Apr 2012 | B2 |
8157852 | Bloom et al. | Apr 2012 | B2 |
8157860 | McNamara et al. | Apr 2012 | B2 |
8157940 | Edwin et al. | Apr 2012 | B2 |
8158041 | Colone | Apr 2012 | B2 |
8187321 | Shanley et al. | May 2012 | B2 |
8202313 | Shanley et al. | Jun 2012 | B2 |
8206435 | Shanley et al. | Jun 2012 | B2 |
8216398 | Bledsoe et al. | Jul 2012 | B2 |
8235916 | Whiting et al. | Aug 2012 | B2 |
8235933 | Keren et al. | Aug 2012 | B2 |
8246677 | Ryan | Aug 2012 | B2 |
8287589 | Otto et al. | Oct 2012 | B2 |
8298150 | Mann et al. | Oct 2012 | B2 |
8298244 | Garcia et al. | Oct 2012 | B2 |
8303511 | Eigler et al. | Nov 2012 | B2 |
8313524 | Edwin et al. | Nov 2012 | B2 |
8328751 | Keren et al. | Dec 2012 | B2 |
8337650 | Edwin et al. | Dec 2012 | B2 |
8348996 | Tuval et al. | Jan 2013 | B2 |
8357193 | Phan et al. | Jan 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8460366 | Rowe | Jun 2013 | B2 |
8468667 | Straubinger et al. | Jun 2013 | B2 |
8480594 | Eigler et al. | Jul 2013 | B2 |
8579966 | Seguin et al. | Nov 2013 | B2 |
8597225 | Kapadia | Dec 2013 | B2 |
8617337 | Layne et al. | Dec 2013 | B2 |
8617441 | Edwin et al. | Dec 2013 | B2 |
8652284 | Bogert et al. | Feb 2014 | B2 |
8665086 | Miller et al. | Mar 2014 | B2 |
8696611 | Nitzan et al. | Apr 2014 | B2 |
8790241 | Edwin et al. | Jul 2014 | B2 |
8882697 | Celermajer et al. | Nov 2014 | B2 |
8882798 | Schwab et al. | Nov 2014 | B2 |
8911489 | Ben-Muvhar | Dec 2014 | B2 |
9005155 | Sugimoto | Apr 2015 | B2 |
9034034 | Nitzan et al. | May 2015 | B2 |
9055917 | Mann et al. | Jun 2015 | B2 |
9060696 | Eigler et al. | Jun 2015 | B2 |
9067050 | Gallagher et al. | Jun 2015 | B2 |
9205236 | McNamara et al. | Dec 2015 | B2 |
9220429 | Nabutovsky et al. | Dec 2015 | B2 |
9232997 | Sugimoto et al. | Jan 2016 | B2 |
9358371 | McNamara et al. | Jun 2016 | B2 |
9393115 | Tabor et al. | Jul 2016 | B2 |
9456812 | Finch et al. | Oct 2016 | B2 |
9622895 | Cohen et al. | Apr 2017 | B2 |
9629715 | Nitzan et al. | Apr 2017 | B2 |
9681948 | Levi et al. | Jun 2017 | B2 |
9707382 | Nitzan et al. | Jul 2017 | B2 |
9713696 | Yacoby et al. | Jul 2017 | B2 |
9724499 | Rottenberg et al. | Aug 2017 | B2 |
9757107 | McNamara et al. | Sep 2017 | B2 |
9789294 | Taft et al. | Oct 2017 | B2 |
9918677 | Eigler et al. | Mar 2018 | B2 |
9943670 | Keren et al. | Apr 2018 | B2 |
9980815 | Nitzan et al. | May 2018 | B2 |
10045766 | McNamara et al. | Aug 2018 | B2 |
10047421 | Khan et al. | Aug 2018 | B2 |
10076403 | Eigler et al. | Sep 2018 | B1 |
10105103 | Goldshtein et al. | Oct 2018 | B2 |
10111741 | Michalak | Oct 2018 | B2 |
10207087 | Keren et al. | Feb 2019 | B2 |
10207807 | Moran et al. | Feb 2019 | B2 |
10251740 | Eigler et al. | Apr 2019 | B2 |
10251750 | Alexander et al. | Apr 2019 | B2 |
10265169 | Desrosiers et al. | Apr 2019 | B2 |
10299687 | Nabutovsky et al. | May 2019 | B2 |
10357320 | Beira | Jul 2019 | B2 |
10357357 | Levi et al. | Jul 2019 | B2 |
10368981 | Nitzan et al. | Aug 2019 | B2 |
10463490 | Rottenberg et al. | Nov 2019 | B2 |
10478594 | Yacoby et al. | Nov 2019 | B2 |
10548725 | Alkhatib et al. | Feb 2020 | B2 |
10561423 | Sharma | Feb 2020 | B2 |
10583002 | Lane et al. | Mar 2020 | B2 |
10639459 | Nitzan et al. | May 2020 | B2 |
10828151 | Nitzan et al. | Nov 2020 | B2 |
10835394 | Nae et al. | Nov 2020 | B2 |
10898698 | Eigler et al. | Jan 2021 | B1 |
10912645 | Rottenberg et al. | Feb 2021 | B2 |
10925706 | Eigler et al. | Feb 2021 | B2 |
10940296 | Keren | Mar 2021 | B2 |
11109988 | Rosen et al. | Sep 2021 | B2 |
11135054 | Nitzan et al. | Oct 2021 | B2 |
11234702 | Eigler et al. | Feb 2022 | B1 |
11253353 | Levi et al. | Feb 2022 | B2 |
11255379 | Baskin et al. | Feb 2022 | B2 |
11291807 | Eigler et al. | Apr 2022 | B2 |
11304831 | Nae et al. | Apr 2022 | B2 |
11382747 | Rottenberg et al. | Jul 2022 | B2 |
11458287 | Eigler et al. | Oct 2022 | B2 |
11497631 | Rosen et al. | Nov 2022 | B2 |
11607327 | Nae et al. | Mar 2023 | B2 |
11612385 | Nae et al. | Mar 2023 | B2 |
11690976 | Yacoby et al. | Jul 2023 | B2 |
11813386 | Nae et al. | Nov 2023 | B2 |
11850138 | Eigler et al. | Dec 2023 | B2 |
11865282 | Nae et al. | Jan 2024 | B2 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20020051730 | Bodnar et al. | May 2002 | A1 |
20020099431 | Armstrong et al. | Jul 2002 | A1 |
20020120277 | Hauschild et al. | Aug 2002 | A1 |
20020165479 | Wilk | Nov 2002 | A1 |
20020165606 | Wolf et al. | Nov 2002 | A1 |
20020169371 | Gilderdale | Nov 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020173742 | Keren et al. | Nov 2002 | A1 |
20020183628 | Reich et al. | Dec 2002 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030045902 | Weadock | Mar 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030125798 | Martin | Jul 2003 | A1 |
20030136417 | Fonseca et al. | Jul 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030176914 | Rabkin et al. | Sep 2003 | A1 |
20030209835 | Chun et al. | Nov 2003 | A1 |
20030216679 | Wolf et al. | Nov 2003 | A1 |
20030216803 | Ledergerber | Nov 2003 | A1 |
20040010219 | McCusker et al. | Jan 2004 | A1 |
20040016514 | Nien | Jan 2004 | A1 |
20040073242 | Chanduszko | Apr 2004 | A1 |
20040077988 | Tweden et al. | Apr 2004 | A1 |
20040088045 | Cox | May 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040102797 | Golden et al. | May 2004 | A1 |
20040116999 | Ledergerber | Jun 2004 | A1 |
20040138743 | Myers et al. | Jul 2004 | A1 |
20040147869 | Wolf et al. | Jul 2004 | A1 |
20040147871 | Burnett | Jul 2004 | A1 |
20040147886 | Bonni | Jul 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040162514 | Alferness et al. | Aug 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040210190 | Kohler et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040225352 | Osborne et al. | Nov 2004 | A1 |
20050003327 | Elian et al. | Jan 2005 | A1 |
20050033327 | Gainor et al. | Feb 2005 | A1 |
20050033351 | Newton | Feb 2005 | A1 |
20050065589 | Schneider et al. | Mar 2005 | A1 |
20050125032 | Whisenant et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050148925 | Rottenberg et al. | Jul 2005 | A1 |
20050165344 | Dobak, III | Jul 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050267524 | Chanduszko | Dec 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20050288596 | Eigler et al. | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060009800 | Christianson et al. | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060052821 | Abbott et al. | Mar 2006 | A1 |
20060111660 | Wolf et al. | May 2006 | A1 |
20060111704 | Brenneman et al. | May 2006 | A1 |
20060116710 | Corcoran et al. | Jun 2006 | A1 |
20060122522 | Chavan et al. | Jun 2006 | A1 |
20060122647 | Callaghan et al. | Jun 2006 | A1 |
20060167541 | Lattouf | Jul 2006 | A1 |
20060184231 | Rucker | Aug 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060256611 | Bednorz et al. | Nov 2006 | A1 |
20060282157 | Hill et al. | Dec 2006 | A1 |
20070010852 | Blaeser et al. | Jan 2007 | A1 |
20070021739 | Weber | Jan 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070073337 | Abbott et al. | Mar 2007 | A1 |
20070129756 | Abbott et al. | Jun 2007 | A1 |
20070191863 | De Juan, Jr. et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070249985 | Brenneman et al. | Oct 2007 | A1 |
20070276413 | Nobles | Nov 2007 | A1 |
20070276414 | Nobles | Nov 2007 | A1 |
20070282157 | Rottenberg et al. | Dec 2007 | A1 |
20070299384 | Faul et al. | Dec 2007 | A1 |
20080034836 | Eigler et al. | Feb 2008 | A1 |
20080086205 | Gordy et al. | Apr 2008 | A1 |
20080125861 | Webler et al. | May 2008 | A1 |
20080171944 | Brenneman et al. | Jul 2008 | A1 |
20080177300 | Mas et al. | Jul 2008 | A1 |
20080243081 | Nance et al. | Oct 2008 | A1 |
20080262602 | Wilk et al. | Oct 2008 | A1 |
20080264102 | Berra | Oct 2008 | A1 |
20080319525 | Tieu et al. | Dec 2008 | A1 |
20090030499 | Bebb et al. | Jan 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090125104 | Hoffman | May 2009 | A1 |
20090149947 | Frohwitter | Jun 2009 | A1 |
20090198315 | Boudjemline | Aug 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100022940 | Thompson | Jan 2010 | A1 |
20100057192 | Celermajer | Mar 2010 | A1 |
20100069836 | Satake | Mar 2010 | A1 |
20100070022 | Kuehling | Mar 2010 | A1 |
20100081867 | Fishler et al. | Apr 2010 | A1 |
20100100167 | Bortlein et al. | Apr 2010 | A1 |
20100121434 | Paul et al. | May 2010 | A1 |
20100179590 | Fortson et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100249491 | Farnan et al. | Sep 2010 | A1 |
20100249909 | McNamara et al. | Sep 2010 | A1 |
20100249910 | McNamara et al. | Sep 2010 | A1 |
20100249915 | Zhang | Sep 2010 | A1 |
20100256548 | McNamara et al. | Oct 2010 | A1 |
20100256753 | McNamara et al. | Oct 2010 | A1 |
20100298755 | McNamara et al. | Nov 2010 | A1 |
20100324652 | Aurilia et al. | Dec 2010 | A1 |
20110022057 | Eigler et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110054515 | Bridgeman et al. | Mar 2011 | A1 |
20110071623 | Finch et al. | Mar 2011 | A1 |
20110071624 | Finch et al. | Mar 2011 | A1 |
20110093059 | Fischell et al. | Apr 2011 | A1 |
20110106149 | Ryan et al. | May 2011 | A1 |
20110152923 | Fox | Jun 2011 | A1 |
20110190874 | Celermajer et al. | Aug 2011 | A1 |
20110218479 | Rottenberg et al. | Sep 2011 | A1 |
20110218480 | Rottenberg et al. | Sep 2011 | A1 |
20110218481 | Rottenberg et al. | Sep 2011 | A1 |
20110251675 | Dwork | Oct 2011 | A1 |
20110257723 | McNamara | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110264203 | Dwork et al. | Oct 2011 | A1 |
20110276086 | Al-Qbandi et al. | Nov 2011 | A1 |
20110295182 | Finch et al. | Dec 2011 | A1 |
20110295183 | Finch et al. | Dec 2011 | A1 |
20110295362 | Finch et al. | Dec 2011 | A1 |
20110295366 | Finch et al. | Dec 2011 | A1 |
20110306916 | Nitzan et al. | Dec 2011 | A1 |
20110319806 | Wardle | Dec 2011 | A1 |
20120022507 | Najafi et al. | Jan 2012 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120035590 | Whiting et al. | Feb 2012 | A1 |
20120041422 | Whiting et al. | Feb 2012 | A1 |
20120046528 | Eigler et al. | Feb 2012 | A1 |
20120046739 | Von Oepen et al. | Feb 2012 | A1 |
20120053686 | McNamara et al. | Mar 2012 | A1 |
20120071918 | Amin et al. | Mar 2012 | A1 |
20120130301 | McNamara et al. | May 2012 | A1 |
20120165928 | Nitzan et al. | Jun 2012 | A1 |
20120179172 | Paul, Jr. et al. | Jul 2012 | A1 |
20120190991 | Bornzin et al. | Jul 2012 | A1 |
20120265296 | McNamara et al. | Oct 2012 | A1 |
20120271277 | Fischell et al. | Oct 2012 | A1 |
20120271398 | Essinger et al. | Oct 2012 | A1 |
20120289882 | McNamara et al. | Nov 2012 | A1 |
20120290062 | McNamara et al. | Nov 2012 | A1 |
20130030521 | Nitzan et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130096965 | Pappas et al. | Apr 2013 | A1 |
20130138145 | Von Oepen | May 2013 | A1 |
20130178783 | McNamara et al. | Jul 2013 | A1 |
20130178784 | McNamara et al. | Jul 2013 | A1 |
20130184633 | McNamara et al. | Jul 2013 | A1 |
20130184634 | McNamara et al. | Jul 2013 | A1 |
20130197423 | Keren et al. | Aug 2013 | A1 |
20130197547 | Fukuoka et al. | Aug 2013 | A1 |
20130197629 | Gainor et al. | Aug 2013 | A1 |
20130204175 | Sugimoto | Aug 2013 | A1 |
20130231737 | McNamara et al. | Sep 2013 | A1 |
20130261531 | Gallagher et al. | Oct 2013 | A1 |
20130281988 | Magnin et al. | Oct 2013 | A1 |
20130304192 | Chanduszko | Nov 2013 | A1 |
20130331864 | Jelich et al. | Dec 2013 | A1 |
20140012181 | Sugimoto et al. | Jan 2014 | A1 |
20140012303 | Heipl | Jan 2014 | A1 |
20140012368 | Sugimoto et al. | Jan 2014 | A1 |
20140012369 | Murry, III et al. | Jan 2014 | A1 |
20140039599 | Berreklouw | Feb 2014 | A1 |
20140067037 | Fargahi | Mar 2014 | A1 |
20140094904 | Salahieh et al. | Apr 2014 | A1 |
20140128795 | Keren et al. | May 2014 | A1 |
20140128796 | Keren et al. | May 2014 | A1 |
20140163449 | Rottenberg et al. | Jun 2014 | A1 |
20140194971 | McNamara | Jul 2014 | A1 |
20140213959 | Nitzan et al. | Jul 2014 | A1 |
20140222144 | Eberhardt et al. | Aug 2014 | A1 |
20140249621 | Eidenschink | Sep 2014 | A1 |
20140257167 | Celermajer | Sep 2014 | A1 |
20140275916 | Nabutovsky et al. | Sep 2014 | A1 |
20140277045 | Fazio et al. | Sep 2014 | A1 |
20140277054 | McNamara et al. | Sep 2014 | A1 |
20140303710 | Zhang et al. | Oct 2014 | A1 |
20140350565 | Yacoby et al. | Nov 2014 | A1 |
20140350658 | Benary et al. | Nov 2014 | A1 |
20140350661 | Schaeffer | Nov 2014 | A1 |
20140350669 | Gillespie et al. | Nov 2014 | A1 |
20140357946 | Golden et al. | Dec 2014 | A1 |
20140364941 | Edmiston et al. | Dec 2014 | A1 |
20150005810 | Center et al. | Jan 2015 | A1 |
20150034217 | Vad | Feb 2015 | A1 |
20150039084 | Levi et al. | Feb 2015 | A1 |
20150066140 | Quadri et al. | Mar 2015 | A1 |
20150073539 | Geiger et al. | Mar 2015 | A1 |
20150112383 | Sherman et al. | Apr 2015 | A1 |
20150119796 | Finch | Apr 2015 | A1 |
20150127093 | Hosmer et al. | May 2015 | A1 |
20150142049 | Delgado et al. | May 2015 | A1 |
20150148731 | McNamara et al. | May 2015 | A1 |
20150148896 | Karapetian et al. | May 2015 | A1 |
20150157455 | Hoang et al. | Jun 2015 | A1 |
20150173897 | Raanani et al. | Jun 2015 | A1 |
20150182334 | Bourang et al. | Jul 2015 | A1 |
20150190229 | Seguin | Jul 2015 | A1 |
20150196383 | Johnson | Jul 2015 | A1 |
20150201998 | Roy et al. | Jul 2015 | A1 |
20150209143 | Duffy et al. | Jul 2015 | A1 |
20150230924 | Miller et al. | Aug 2015 | A1 |
20150238314 | Bortlein et al. | Aug 2015 | A1 |
20150245908 | Nitzan et al. | Sep 2015 | A1 |
20150272731 | Racchini et al. | Oct 2015 | A1 |
20150282790 | Quinn et al. | Oct 2015 | A1 |
20150282931 | Brunnett et al. | Oct 2015 | A1 |
20150294313 | Kamal et al. | Oct 2015 | A1 |
20150313599 | Johnson et al. | Nov 2015 | A1 |
20150335801 | Farnan et al. | Nov 2015 | A1 |
20150359556 | Vardi | Dec 2015 | A1 |
20160007924 | Eigler et al. | Jan 2016 | A1 |
20160022423 | McNamara et al. | Jan 2016 | A1 |
20160022970 | Forcucci et al. | Jan 2016 | A1 |
20160045165 | Braido et al. | Feb 2016 | A1 |
20160045311 | McCann et al. | Feb 2016 | A1 |
20160073907 | Nabutovsky et al. | Mar 2016 | A1 |
20160120550 | McNamara et al. | May 2016 | A1 |
20160129260 | Mann et al. | May 2016 | A1 |
20160157862 | Hernandez et al. | Jun 2016 | A1 |
20160166381 | Sugimoto et al. | Jun 2016 | A1 |
20160184561 | McNamara et al. | Jun 2016 | A9 |
20160206423 | O'Connor et al. | Jul 2016 | A1 |
20160213467 | Backus et al. | Jul 2016 | A1 |
20160220360 | Lin et al. | Aug 2016 | A1 |
20160220365 | Backus et al. | Aug 2016 | A1 |
20160262878 | Backus et al. | Sep 2016 | A1 |
20160262879 | Meiri et al. | Sep 2016 | A1 |
20160287386 | Alon et al. | Oct 2016 | A1 |
20160296325 | Edelman et al. | Oct 2016 | A1 |
20160361167 | Tuval et al. | Dec 2016 | A1 |
20160361184 | Tabor et al. | Dec 2016 | A1 |
20170035435 | Amin et al. | Feb 2017 | A1 |
20170056171 | Cooper et al. | Mar 2017 | A1 |
20170112624 | Patel | Apr 2017 | A1 |
20170113026 | Finch | Apr 2017 | A1 |
20170128705 | Forcucci et al. | May 2017 | A1 |
20170135685 | McNamara et al. | May 2017 | A9 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165532 | Khan et al. | Jun 2017 | A1 |
20170216025 | Nitzan et al. | Aug 2017 | A1 |
20170224323 | Rowe et al. | Aug 2017 | A1 |
20170224444 | Viecilli et al. | Aug 2017 | A1 |
20170231766 | Hariton et al. | Aug 2017 | A1 |
20170273790 | Vettukattil et al. | Sep 2017 | A1 |
20170281339 | Levi et al. | Oct 2017 | A1 |
20170312486 | Nitzan et al. | Nov 2017 | A1 |
20170319823 | Yacoby et al. | Nov 2017 | A1 |
20170325956 | Rottenberg et al. | Nov 2017 | A1 |
20170340460 | Rosen et al. | Nov 2017 | A1 |
20170348100 | Lane et al. | Dec 2017 | A1 |
20180028314 | Ekvall et al. | Feb 2018 | A1 |
20180099128 | McNamara et al. | Apr 2018 | A9 |
20180104053 | Alkhatib et al. | Apr 2018 | A1 |
20180110609 | Ehnes et al. | Apr 2018 | A1 |
20180125630 | Hynes et al. | May 2018 | A1 |
20180130988 | Nishikawa et al. | May 2018 | A1 |
20180200496 | Kratzberg et al. | Jul 2018 | A1 |
20180243071 | Eigler | Aug 2018 | A1 |
20180256865 | Finch et al. | Sep 2018 | A1 |
20180263766 | Nitzan et al. | Sep 2018 | A1 |
20180280667 | Keren | Oct 2018 | A1 |
20180280668 | Alaswad | Oct 2018 | A1 |
20180344994 | Karavany et al. | Dec 2018 | A1 |
20190000327 | Doan et al. | Jan 2019 | A1 |
20190008628 | Eigler et al. | Jan 2019 | A1 |
20190015103 | Sharma | Jan 2019 | A1 |
20190015188 | Eigler et al. | Jan 2019 | A1 |
20190021861 | Finch | Jan 2019 | A1 |
20190083076 | Alanbaei | Mar 2019 | A1 |
20190110911 | Nae et al. | Apr 2019 | A1 |
20190239754 | Nabutovsky et al. | Aug 2019 | A1 |
20190254814 | Nitzan et al. | Aug 2019 | A1 |
20190262118 | Eigler et al. | Aug 2019 | A1 |
20190328513 | Levi et al. | Oct 2019 | A1 |
20190336163 | McNamara et al. | Nov 2019 | A1 |
20200060825 | Rottenberg et al. | Feb 2020 | A1 |
20200078196 | Rosen et al. | Mar 2020 | A1 |
20200078558 | Yacoby et al. | Mar 2020 | A1 |
20200085600 | Schwartz et al. | Mar 2020 | A1 |
20200197178 | Vecchio | Jun 2020 | A1 |
20200261705 | Nitzan et al. | Aug 2020 | A1 |
20200315599 | Nae et al. | Oct 2020 | A1 |
20200368505 | Nae et al. | Nov 2020 | A1 |
20210022507 | Williams | Jan 2021 | A1 |
20210052378 | Nitzan et al. | Feb 2021 | A1 |
20210100665 | Nae et al. | Apr 2021 | A1 |
20210121179 | Ben-David et al. | Apr 2021 | A1 |
20210205590 | Fahey et al. | Jul 2021 | A1 |
20220008014 | Rowe et al. | Jan 2022 | A1 |
20220211361 | Rolando et al. | Jul 2022 | A1 |
20220304803 | Guyenot et al. | Sep 2022 | A1 |
Number | Date | Country |
---|---|---|
2003291117 | Apr 2009 | AU |
2378920 | Feb 2001 | CA |
101505680 | Aug 2009 | CN |
105555204 | May 2016 | CN |
108451569 | Aug 2018 | CN |
1987777 | Nov 2008 | EP |
2238933 | Oct 2010 | EP |
2305321 | Apr 2011 | EP |
1965842 | Nov 2011 | EP |
3400907 | Nov 2018 | EP |
2827153 | Jan 2003 | FR |
WO-9531945 | Nov 1995 | WO |
WO-9702850 | Jan 1997 | WO |
WO-9727898 | Aug 1997 | WO |
WO-9960941 | Dec 1999 | WO |
WO-0044311 | Aug 2000 | WO |
WO-0050100 | Aug 2000 | WO |
WO-0110314 | Feb 2001 | WO |
WO-0126585 | Apr 2001 | WO |
WO-0191828 | Dec 2001 | WO |
WO-0226281 | Apr 2002 | WO |
WO-02071974 | Sep 2002 | WO |
WO-02087473 | Nov 2002 | WO |
WO-03053495 | Jul 2003 | WO |
WO-2005027752 | Mar 2005 | WO |
WO-2005074367 | Aug 2005 | WO |
WO-2006127765 | Nov 2006 | WO |
WO-2007083288 | Jul 2007 | WO |
WO-2008055301 | May 2008 | WO |
WO-2008070797 | Jun 2008 | WO |
WO-2009029261 | Mar 2009 | WO |
WO-2010128501 | Nov 2010 | WO |
WO-2010129089 | Nov 2010 | WO |
WO-2010139771 | Dec 2010 | WO |
WO-2010139771 | Jan 2011 | WO |
WO-2011062858 | May 2011 | WO |
WO-2013096965 | Jun 2013 | WO |
WO-2013172474 | Nov 2013 | WO |
WO-2016178171 | Nov 2016 | WO |
WO-2017118920 | Jul 2017 | WO |
WO-2018158747 | Sep 2018 | WO |
WO-2019015617 | Jan 2019 | WO |
WO-2019085841 | May 2019 | WO |
WO-2019109013 | Jun 2019 | WO |
WO-2019142152 | Jul 2019 | WO |
WO-2019179447 | Sep 2019 | WO |
WO-2019212812 | Nov 2019 | WO |
WO-2019218072 | Nov 2019 | WO |
WO-2020206062 | Oct 2020 | WO |
WO-2020257530 | Dec 2020 | WO |
WO-2021050589 | Mar 2021 | WO |
WO-2021113670 | Jun 2021 | WO |
WO-2021212011 | Oct 2021 | WO |
WO-2021224736 | Nov 2021 | WO |
WO-2022046921 | Mar 2022 | WO |
WO-2022076601 | Apr 2022 | WO |
WO-2022091018 | May 2022 | WO |
WO-2022091019 | May 2022 | WO |
WO-2022103973 | May 2022 | WO |
Entry |
---|
Abraham et al., “Hemodynamic Monitoring in Advanced Heart Failure: Results from the LAPTOP-HF Trial,” J Card Failure, 22:940 (2016) (Abstract Only). |
Abraham et al., “Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial,” The Lancet, http://dx.doi.org/10.1016/S0140-6736(15)00723-0 (2015). |
Abraham et al., “Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial,” The Lancet, DOI:10.1016/S0140-6736(11)60101-3 (2011). |
Abreu et al., “Doppler ultrasonography of the femoropopliteal segment in patients with venous ulcer,” J Vasc Bras., 11(4):277-285 (2012). |
Adamson et al., “Ongoing Right Ventricular Hemodynamics in Heart Failure Clinical Value of Measurements Derived From an Implantable Monitoring System,” J Am Coll Cardiol., 41(4):565-571 (2003). |
Adamson et al., “Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction,” Circ Heart Fail., 7:935-944 (2014). |
Ambrosy et al. “The Global Health and Economic Burden of Hospitalizations for Heart Failure,” J Am Coll Cardiol., 63:1123-1133 (2014). |
Aminde et al., “Current diagnostic and treatment strategies for Lutembacher syndrome: the pivotal role of echocardiography,” Cardiovasc Diagn Ther., 5(2):122-132 (2015). |
Anderas E. “Advanced MEMS Pressure Sensors Operating in Fluids,” Digital Comprehensive Summaries of Uppsala Dissertation from the Faculty of Science and Technology 933. Uppsala ISBN 978-91-554-8369-2 (2012). |
Anderas et al., “Tilted c-axis Thin-Film Bulk Wave Resonant Pressure Sensors with Improved Sensitivity,” IEEE Sensors J., 12(8):2653-2654 (2012). |
Ando, et al., Left ventricular decompression through a patent foramen ovale in a patient with hypertrophic cardiomyopathy: A case report, Cardiovascular Ultrasound, 2: 1-7 (2004). |
Article 34 Amendments dated May 28, 2013 in Int'l PCT Patent Appl. Serial No. PCT/IB2012/001859 (0810). |
Article 34 Amendments dated Nov. 27, 2012 in Int'l PCT Patent Appl. Serial No. PCT/IL2011/000958 (0710). |
Ataya et al., “A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy,” J. Clin. Med., 5(12):114(2016). |
“Atrium Advanta V12, Balloon Expandable Covered Stent, Improving Patient Outcomes with An Endovascular Approach, ” Brochure, 8 pages, Getinge (2017). |
Bannan et al., “Characteristics of Adult Patients with Atrial Septal Defects Presenting with Paradoxical Embolism.,” Catheterization and Cardiovascular Interventions, 74:1066-1069 (2009). |
Baumgartner et al., “ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)—The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC),” Eur Heart J., 31:2915-2957 (2010). |
Beemath et al., “Pulmonary Embolism as a Cause of Death in Adults Who Died With Heart Failure,” Am J Cardiol., 98:1073-1075 (2006). |
Benza et al., “Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor,” CHEST, 156(6):1176-1186 (2019). |
Boehm, et al., “Balloon Atrial Septostomy: History and Technique,” Images Paeditr. Cardiol., 8(1):8-14 (2006). |
Braunwald, Heart Disease, Chapter 6, pp. 186. |
Bridges, et al., “The Society of Thoracic Surgeons Practice Guideline Series: Transmyocardial Laser Revascularization,” Ann Thorac Surg., 77:1494-1502 (2004). |
Bristow, et al., “Improvement in cardiac myocite function by biological effects of medical therapy: a new concept in the treatment of heart failure,” European Heart Journal, 16 (Suppl.F):20-31 (1995). |
Bruch et al., “Fenestrated Occluders for Treatment of ASD in Elderly Patients with Pulmonary Hypertension and/or Right Heart Failure,” J Interven Cardiol., 21(1):44-49 (2008). |
Burkhoff et al., “Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers,” Am J Physiol Heart Circ Physiol., 289:H501-H512 (2005). |
Butler et al. “Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials,” JAMA., 312(8):789-790 (2014). |
Case, et al., “Relief of High Left-Atrial Pressure in Left-Ventricular Failure,” Lancet, (pp. 841-842), Oct. 17, 1964. |
Chakko et al., “Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care,” Am J Medicine, 90:353-359 (1991) (Abstract Only). |
Chang et al., “State-of-the-art and recent developments in micro/nanoscale pressure sensors for smart wearable devices and health monitoring systems,” Nanotechnology and Precision Engineering, 3:43-52 (2020). |
Chen et al., “Continuous wireless pressure monitoring and mapping with ultra-small passive sensors for health monitoring and critical care,” Nature Communications, 5(1):1-10 (2014). |
Chen et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, 306(15):1669-1678 (2011). |
Chiche et al., “Prevalence of patent foramen ovale and stroke in pulmonary embolism patients,” Eur Heart J., 34:P1142 (2013) (Abstract Only). |
Chin et al., “The right ventricle in pulmonary hypertension,” Coron Artery Dis., 16(1):13-18 (2005) (Abstract Only). |
Chun et al., “Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure,” Circ Heart Fail., 5:414-421 (2012). |
Ciarka et al., “Atrial Septostomy Decreases Sympathetic Overactivity in Pulmonary Arterial Hypertension,” Chest, 131(6):P1831-1837 (2007) (Abstract Only). |
Cleland et al., “The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe—Part 1: patient characteristics and diagnosis,” Eur Heart J., 24:442-463 (2003). |
Clowes et al., “Mechanisms of Arterial Graft Healing—Rapid Transmural Capillary Ingrowth Provides a Source of Intimal Endothelium and Smooth Muscle in Porous PTFE Prostheses,” Am J Pathol., 123:220-230 (1986). |
Coats, et al., “Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function,” Circulation, 85: 2119-2131 (1992). |
Davies et al., “Abnormal left heart function after operation for atrial septal defect,” British Heart Journal, 32:747-753 (1970). |
Davies, et al., “Reduced Contraction and Altered Frequency Response of Isolated Ventricular Myocytes From Patients With Heart Failure, Circulation,” 92: 2540-2549 (1995). |
Del Trigo et al., “Unidirectional Left-To-Right Interatrial Shunting for Treatment of Patients with Heart Failure with Reduced Ejection Fraction: a Safety and Proof-of-Principle Cohort Study,” Lancet, 387:1290-1297 (2016). |
Della Lucia et al., “Design, fabrication and characterization of SAW pressure sensors for offshore oil and gas exploration,” Sensors and Actuators A: Physical, 222:322-328 (2015). |
Drazner et al., “Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure,” N Engl J Med., 345(8):574-81 (2001). |
Drazner et al., “Relationship between Right and Left-Sided Filling Pressures in 1000 Patients with Advanced Heart Failure,” Heart Lung Transplant, 18:1126-1132 (1999). |
Drexel, et al., “The Effects of Cold Work and Heat Treatment on the Properties of Nitinol Wire, Proceedings of the International Conference on Shape Memory and Superelastic Technologies, SMST 2006,” Pacific Grove, California, USA (pp. 447-454) May 7-11, 2006. |
Eigler et al., “Cardiac Unloading with an Implantable Interatrial Shunt in Heart Failure: Serial Observations in an Ovine Model of Ischemic Cardiomyopathy,” Structural Heart, 1:40-48 (2017). |
Eigler, et al., Implantation and Recovery of Temporary Metallic Stents in Canine Coronary Arteries, JACC, 22(4):1207-1213 (1993). |
Ennezat, et al., An unusual case of low-flow, low gradient severe aortic stenosis: Left-to-right shunt due to atrial septal defect, Cardiology, 113(2):146-148, (2009). |
Eshaghian et al., “Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure,” Am J Cardiol., 97:1759-1764 (2006). |
Ewert, et al., Acute Left Heart Failure After Interventional Occlusion of An Artial Septal Defect, Z Kardiol, 90(5): 362-366 (May 2001). |
Ewert, et al., Masked Left Ventricular Restriction in Elderly Patients With Atrial Septal Defects: A Contraindication for Closure?, Catheterization and Cardiovascular Intervention, 52:177-180 (2001). |
Extended European Search Report dated Jan. 8, 2015 in EP Patent Appl No. 10772089.8. (0530). |
Extended European Search Report dated Mar. 29, 2019 in EP Patent Appl. Serial No. EP16789391 (1830). |
Extended European Search Report dated Sep. 19, 2006 in EP Patent Appl No. 16170281.6 (0731). |
Feldman et al., “Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (Reduce LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]), A Phase 2, Randomized, Sham-Controlled Trial,” Circulation, 137:364-375 (2018). |
Ferrari et al., “Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers: results from an international survey,” Eur Respir J., 42:26312 (2013) (Abstract Only). |
Fonarow et al., “Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure,” J Am Coll Cardiol., 50(8):768-777 (2007). |
Fonarow et al., “Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure: Classification and Regression Tree Analysis,” JAMA, 293(5):572-580 (2005). |
Fonarow, G., “The Treatment Targets in Acute Decompensated Heart Failure,” Rev Cardiovasc Med., 2:(2):S7-S12 (2001). |
Galie et al., “2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension—The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),” European Heart Journal, 37:67-119 (2016). |
Galie et al., “Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses,” Eur Heart J., 31:2080-2086 (2010). |
Galipeau et al., “Surface acoustic wave microsensors and applications,” Smart Materials and Structures, 6(6):658-667 (1997) (Abstract Only). |
Geiran, et al., Changes in cardiac dynamics by opening an interventricular shunt in dogs, J. Surg. Res. 48(1):6-12 (1990). |
Gelernter-Yaniv, et al., Transcatheter ClosureoOf Left-To-Right Interatrial Shunts to Resolve Hypoxemia, Congenit. Heart Dis. 31(1): 47-53 (Jan. 2008). |
Geva et al., “Atrial septal defects,” Lancet, 383:1921-32 (2014). |
Gewillig, et al., Creation with a stent of an unrestrictive lasting atrial communication, Cardio. Young 12(4): 404-407 (2002). |
Gheorghiade et al., “Acute Heart Failure Syndromes, Current State and Framework for Future Research,” Circulation, 112:3958-3968 (2005). |
Gheorghiade et al., “Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure A Randomized Controlled Trial,” JAMA., 291:1963-1971 (2004). |
Go et al. “Heart Disease and Stroke Statistics—2014 Update—A Report From the American Heart Association,” Circulation, 128:1-267 (2014). |
Guillevin et al., “Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives,” Eur Respir Rev., 22:535-542 (2013). |
Guyton et al., “Effect of Elevated Left Atrial Pressure and Decreased Plasma Protein Concentration on the Development of Pulmonary Edema,” Circulation Research, 7:643-657 (1959). |
Hasenfub, et al., A Transcatheter Intracardiac Shunt Device for Heart Failure with Preserved Ejection Fraction (Reduce LAP-HF): A Multicentre, Open-Label, Single-Arm, Phase 1 Trial, www.thelancet.com, 387:1298-1304 (2016). |
Hoeper et al., “Definitions and Diagnosis of Pulmonary Hypertension,” J Am Coll Cardiol., 62(5):D42-D50 (2013). |
Hogg et al., “Heart Failure With Preserved Left Ventricular Systolic Function. Epidemiology, Clinical Characteristics, and Prognosis,” J Am Coll Cardiol., 43(3):317-327 (2004). |
Howell et al., “Congestive heart failure and outpatient risk of venous thromboembolism: A retrospective, case-control study,” Journal of Clinical Epidemiology, 54:810-816 (2001). |
Huang et al., “Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses,” Am J Physiol Heart Circ Physiol., 286:H2141-H2150 (2004). |
Humbert et al., “Pulmonary Arterial Hypertension in France—Results from a National Registry,” Am J Respir Crit Care Med., 173:1023-1030 (2006). |
International Search Report & Written Opinion dated Nov. 7, 2016 in Int'l PCT Patent Appl. Serial No. PCT/IB2016/052561 (1810). |
International Search Report & Written Opinion dated May 29, 2018 in Int'l PCT Patent Appl. Serial No. PCT/IB2018/051385 (1310). |
International Search Report & Written Opinion dated Feb. 6, 2013 in Int'l PCT Patent Appl. No. PCT/IB2012/001859, 12 pages (0810). |
International Search Report & Written Opinion dated Feb. 7, 2020 in Int'l PCT Patent Appl. Serial No. PCT/IB2019/060257 (1410). |
International Search Report & Written Opinion dated May 13, 2019 in Int'l PCT Patent Appl. No. PCT/IB2019/050452 (1610). |
International Search Report & Written Opinion dated May 29, 2018 in Int'l PCT Patent Appl. Serial No. PCTIB2018/051355 (1310). |
International Search Report & Written Opinion dated Jul. 14, 2020 in Int'l PCT Patent Appl. Serial No. PCT/IB2020/053832 (1210). |
International Search Report & Written Opinion dated Jul. 20, 2020 in Int'l PCT Patent Appl. Serial No. PCT/IB2020/054699 (1710 PCT). |
International Search Report & Written Opinion dated Aug. 12, 2020 in Int'l PCT Patent Appl. Serial No. PCT/IB2020/053118 (1010). |
International Search Report & Written Opinion dated Aug. 28, 2012 in Int'l PCT Patent Appl. No. PCT/IL2011/000958 (0710). |
International Search Report & Written Opinion dated Sep. 21, 2020 in Int'l PCT Patent Appl. Serial No. PCT/IB2020/054306 (1510). |
International Search Report & Written Opinion dated Oct. 11, 2017 in Int'l PCT Patent Appl. Serial No. PCT/IB2017/053188 (1110). |
International Search Report & Written Opinion dated Oct. 26, 2007 in Int'l PCT Patent Appl. Serial No. PCT/IB07/50234 (0610). |
International Search Report dated Apr. 7, 2008 in Int'l PCT Patent Appl. Serial No. PCT/IL05/00131 (0410). |
International Search Report dated Aug. 25, 2010 in Intl PCT Patent Appl. Serial No. PCT/IL2010/000354 (0510). |
ISR & Written Opinion dated Feb. 16, 2015 in Int'l PCT Patent Appl. Serial No. PCT/IB2014/001771 (0910). |
Jessup et al. “2009Focused Update: ACC/AHA Guidelines for the Diagnosisand Management of Heart Failure in Adults: A Report of the American College ofCardiology Foundation/American Heart Association Task Force on PracticeGuidelines: Developed in Collaboration With the International Society for Heartand Lung Transplantation,” J. Am. Coll. Cardiol., 53:1343-1382 (2009). |
Jiang, G., “Design challenges of implantable pressure monitoring system,” Frontiers in Neuroscience, 4(29):1-4 (2010). |
Kane et al., “Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension,” Chest, 139(6):1285-1293 (2011) (Abstract Only). |
Kaye et al., “Effects of an Interatrial Shunt on Rest and Exercise Hemodynamics: Results of a Computer Simulation in Heart Failure,” Journal of Cardiac Failure, 20(3): 212-221 (2014). |
Kaye et al., “One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction,” Circulation: Heart Failure, 9(12):e003662 (2016). |
Keogh et al., “Interventional and Surgical Modalitiesof Treatment in Pulmonary Hypertension,” J Am Coll Cardiol., 54:S67-77 (2009). |
Khositseth et al., Transcatheter Amplatzer Device Closure of Atrial Septal Defect and Patent Foramen Ovale in Patients With Presumed Paradoxical Embolism, Mayo Clinic Proc., 79:35-41 (2004). |
Kramer, et al., Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study, Circulation, 67(4): 807-816, 1983. |
Kretschmar et al., “Shunt Reduction With a Fenestrated Amplatzer Device,” Catheterization and Cardiovascular Interventions, 76:564-571 (2010). |
Kropelnicki et al., “CMOS-compatible ruggedized high-temperature Lamb wave pressure sensor,” J. Micromech. Microeng., 23:085018 pp. 1-9 (2013). |
Krumholz et al., “Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission,” Circ Cardiovasc Qual Outcomes, 2:407-413 (2009). |
Kulkarni et al., “Lutembacher's syndrome,” J Cardiovasc Did Res., 3(2):179-181 (2012). |
Kurzyna et al., “Atrial Septostomy in Treatment of End-Stage Right Heart Failure in Patients With Pulmonary Hypertension,” Chest, 131:977-983 (2007). |
Lai et al., Bidirectional Shunt Through a Residual Atrial Septal Defect After Percutaneous Transvenous Mitral Commissurotomy, Cadiology, 83(3): 205-207 (1993). |
Lammers et al., “Efficacy and Long-Term Patency of Fenerstrated Amplatzer Devices in Children,” Catheter Cardiovasc Interv., 70:578-584 (2007). |
Lemmer, et al., Surgical Implications of Atrial Septal Defect Complicating Aortic Balloon Valvuloplasty, Ann. thorac. Surg, 48(2):295-297 (Aug. 1989). |
Lindenfeld et al. “Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline,” J. Cardiac Failure, 16(6):475-539 (2010). |
Luo, Yi, Selective and Regulated RF Heating of Stent Toward Endohyperthermia Treatment of In-Stent Restenosis, A Thesis Submitted in Partial Fulfillment of The Requirements For The Degree of Master of Applied Science in The Faculty of Graduate and Postdoctoral Studies (Electrical and Computer Engineering), The University of British Columbia, Vancouver, Dec. 2014. |
MacDonald et al., “Emboli Enter Penetrating Arteries of Monkey Brain in Relation to Their Size,” Stroke, 26:1247-1251 (1995). |
Maluli et al., “Atrial Septostomy: A Contemporary Review,” Clin. Cardiol., 38(6):395-400 (2015). |
Maurer et al., “Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF),” Journal of Cardiac Failure., 21(6): 479-488 (2015). |
McClean et al., “Noninvasive Calibration of Cardiac Pressure Transducers in Patients With Heart Failure: An Aid to Implantable Hemodynamic Monitoring and Therapeutic Guidance,” J Cardiac Failure, 12(7):568-576 (2006). |
McLaughlin et al., “Management of Pulmonary Arterial Hypertension,” J Am Coll Cardiol., 65(18):1976-1997 (2015). |
McLaughlin et al., “Survival in Primary Pulmonary Hypertension—The Impact of Epoprostenol Therapy.,” Circulation, 106:1477-1482 (2002). |
Merriam-Webster OnLine Dictionary, Definition of “chamber”, printed Dec. 20, 2004. |
Mu et al., “Dual mode acoustic wave sensor for precise pressure reading,” Applied Physics Letters, 105:113507-1-113507-5 (2014). |
Nagaragu et al., “A 400μW Differential FBAR Sensor Interface IC with digital readout,” IEEE., pp. 218-221 (2015). |
Noordegraaf et al., “The role of the right ventricle in pulmonary arterial hypertension,” Eur Respir Rev., 20(122):243-253 (2011). |
O'Byrne et al., “The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertension,” Cardiology in the Young, 17(5):557-559 (2007) (Abstract Only). |
Oktay et al., “The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction,” Curr Heart Fail Rep., 10(4):1-17 (2013). |
Owan et al., “Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction,” N Engl J Med., 355:251-259 (2006). |
Paitazoglou et al., “Title: The Afr-Prelieve Trial: A prospective, non-randomized, pilot study to assess the Atrial Flow Regulator (AFR) in Heart Failure Patients with either preserved or reduced ejection fraction,” EuroIntervention, 28:2539-50 (2019). |
Park Blade Septostomy Catheter Instructions for Use, Cook Medical, 28 pages, Oct. 2015. |
Park, et al., Blade Atrial Septostomy: Collaborative Study, Circulation, 66(2):258-266 (1982). |
Partial Supplemental European Search Report dated Dec. 11, 2018 in EP Patent Appl. Serial No. 16789391.6 (1830). |
Peters et al., “Self-fabricated fenestrated Amplatzer occluders for transcatheter closure of atrial septal defect in patients with left ventricular restriction: midterm results,” Clin Res Cardiol., 95:88-92 (2006). |
Ponikowski et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC),” Eur Heart J., doi:10.1093/eurheartj/ehw128 (2016). |
Potkay, J. A., “Long term, implantable blood pressure monitoring systems,” Biomed Microdevices, 10:379-392 (2008). |
Pretorious et al., “An Implantable Left Atrial Pressure Sensor Lead Designed for Percutaneous Extraction Using Standard Techniques,” PACE, 00:1-8 (2013). |
Rajeshkumar et al., “Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension,” Catheter Cardiovasc Interv., 1-9 (2017). |
Rich et al., “Atrial Septostomy as Palliative Therapy for Refractory Primary Pulmonary Hypertension,” Am J Cardiol., 51:1560-1561 (1983). |
Ritzema et al., “Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients—Initial Experience With a New Permanent Implantable Device,” Circulation, 116:2952-2959 (2007). |
Ritzema et al., “Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure,” Circulation, 121:1086-1095 (2010). |
Roberts et al., “Integrated microscopy techniques for comprehensive pathology evaluation of an implantable left atrial pressure sensor,” J Histotechnology, 36(1):17-24 (2013). |
Rodes-Cabau et al., “Interatrial Shunting for Heart Failure Early and Late Results From the First-in-Human Experience With the V-Wave System,” J Am Coll Cardiol Intv., 11:2300-2310.doi:10.1016/j.cin.2018.07.001 (2018). |
Rosenquist et al., Atrial Septal Thickness and Area in Normal Heart Specimens and in Those With Ostium Secundum Atrial Septal Defects, J. Clin. Ultrasound, 7:345-348 (1979). |
Ross et al., “Interatrial Communication and Left Atrial Hypertension—A Cause of Continuous Murmur,” Circulation, 28:853-860 (1963). |
Rossignol, et al., Left-to-Right Atrial Shunting: New Hope for Heart Failure, www.thelancet.com, 387:1253-1255 (2016). |
Roven, Effect of Compromising Right Ventricular Function in Left Ventricular Failure by Means of Interatrial and Other Shunts 24:209-219 (Aug. 1969). |
Salehian, et al., Improvements in Cardiac Form and Function After Transcatheter Closure of Secundum Atrial Septal Defects, Journal of the American College of Cardiology, 45(4):499-504 (2005). |
Sandoval et al., “Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension,” Eur Respir J., 38:1343-1348 (2011). |
Sandoval et al., “Graded Balloon Dilation Atrial Septostomy in Severe Primary Pulmonary Hypertension—A Therapeutic Alternative for Patients Nonresponsive to Vasodilator Treatment,” JACC, 32(2):297-304 (1998). |
Schiff et al., “Decompensated heart failure: symptoms, patterns of onset, and contributing factors,” Am J. Med., 114(8):625-630 (2003) (Abstract Only). |
Schmitto, et al., Chronic Heart Failure Induced by Multiple Sequential Coronary Microembolization in sheep, The International Journal of Artificial Organs, 31(4):348-353 (2008). |
Schneider et al., “Fate of a Modified Fenestration of Atrial Septal Occluder Device after Transcatheter Closure of Atrial Septal Defects in Elderly Patients,” J Interven Cardiol., 24:485-490 (2011). |
Scholl et al., “Surface Acoustic Wave Devices for Sensor Applications,” Phys Status Solidi Appl Res., 185(1):47-58 (2001) (Abstract Only). |
Schubert, et al., Left ventricular Conditioning in the Elderly Patient to Prevent Congestive Heart Failure After Transcatheter Closure of the Atrial Septal Defect, Catheterization and Cardiovascular Interventions, 64(3): 333-337 (2005). |
Setoguchi et al., “Repeated hospitalizations predict mortality in the community population with heart failure,” Am Heart J., 154:260-266 (2007). |
Shah et al., “Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction—5-Year Outcomes,” J Am Coll Cardiol., https://doi.org/10.1016/j.jacc.2017.08.074 (2017). |
Shah et al., “One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF I) Trial—A Randomized Clinical Trial,” JAMA Cardiol. doi:10.1001/jamacardio.2018.2936 (2018). |
Sitbon et al., “Selexipag for the Treatment of Pulmonary Arterial Hypertension.,” N Engl J Med., 373(26):2522-2533 (2015). |
Sitbon et al., “Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience,” Eur Respir Rev., 26:160055:1-14 (2017). |
Steimle et al., “Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure,” Circulation, 96:1165-1172 (1997). |
Stevenson et al., “The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure,” JAMA, 261(6):884-888 (1989) (Abstract Only). |
Stormer, et al., Comparative Study of in Vitro Flow Characteristics Between a Human Aortic Valve and a Designed Aortic Valve and Six Corresponding Types of Prosthetic Heart Valves, European Surgical Research 8(2):117-131 (1976). |
Stumper, et al., Modified Technique of Stent Fenestration of the Atrial Septum, Heart, 89:1227-1230, (2003). |
Su et al., “A film bulk acoustic resonator pressure sensor based on lateral field excitation,” International Journal of DistributedSensor Networks, 14(11):1-8 (2018). |
Supplementary European Search Report dated Nov. 13, 2009 in EP Patent Appl. Serial No. 05703174.2 (0430). |
Thenappan et al., “Evolving Epidemiology of Pulmonary Arterial Hypertension,” Am J Resp Critical Care Med., 186:707-709 (2012). |
Tomai et al., “Acute Left Ventricular Failure After Transcatheter Closure of a Secundum Atrial Septal Defect in a Patient With Coronary Artery Disease: A Critical Reappraisal,” Catheterization and Cardiovascular Interventions, 55:97-99 (2002). |
Torbicki et al., “Atrial Septostomy,” The Right Heart, 305-316 (2014). |
Trainor, et al., Comparative Pathology of an Implantable Left Atrial Pressure Sensor, ASAIO Journal, Clinical Cardiovascular/Cardiopulmonary Bypass, 59(5):486-492 (2013). |
Troost et al., “A Modified Technique of Stent Fenestration of the Interatrial Septum Improves Patients With Pulmonary Hypertension,” Catheterization and Cardiovascular Interventions, 73:173179 (2009). |
Troughton et al., “Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance,” J. of Cardiovasc. Trans. Res., 4:3-13 (2011). |
Vank-Noordegraaf et al., “Right Heart Adaptation to Pulmonary Arterial Hypertension—Physiology and Pathobiology,” J Am Coll Cardiol., 62(25):D22-33 (2013). |
Verel et al., “Comparison of left atrial pressure and wedge pulmonary capillary pressure—Pressure gradients between left atrium and left ventricle,” British Heart J., 32:99-102 (1970). |
Viaene et al., “Pulmonary oedema after percutaneous ASD-closure,” Acta Cardiol., 65(2):257-260 (2010). |
Wang et al., “A Low Temperature Drifting Acoustic Wave Pressure Sensor with an Integrated Vacuum Cavity for Absolute Pressure Sensing,” Sensors, 20(1788):1-13 (2020). |
Warnes et al., “ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease—A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease),” JACC, 52(23):e143-e263 (2008). |
Webb et al., “Atrial Septal Defects in the Adult Recent Progress and Overview,” Circulation, 114:1645-1653 (2006). |
Wiedemann, H.R., “Earliest description by Johann Friedrich Meckel, Senior (1750) of what is known today as Lutembacher syndrome (1916),” Am J Med Genet., 53(1):59-64 (1994) (Abstract Only). |
Written Opinion of the International Searching Authority dated Apr. 7, 2008 in Int'l PCT Patent Appl. Serial No. PCT/IL05/00131 (0410). |
Yantchev et al., “Thin Film Lamb Wave Resonators in Frequency Control and Sensing Applications: A Review,” Journal of Micromechanics and Microengineering, 23(4):043001 (2013). |
Zhang et al., “Acute left ventricular failure after transcatheter closure of a secundum atrial septal defect in a patient with hypertrophic cardiomyopathy,” Chin Med J., 124(4):618-621 (2011). |
Zhang et al., “Film bulk acoustic resonator-based high-performance pressure sensor integrated with temperature control system,” J Micromech Microeng., 27(4):1-10 (2017). |
Zhou, et al., Unidirectional Valve Patch for Repair of Cardiac Septal Defects with Pulmonary Hypertension, Annals of Thoracic Surgeons, 60:1245-1249, (1995). |
U.S. Appl. No. 09/839,643 / now U.S. Pat. No. 8,091,556, filed Apr. 20, 2001 / Jan. 10, 2012. |
U.S. Appl. No. 10/597,666 / now U.S. Pat. No. 8,070,708, filed Jun. 20, 2007 / Dec. 6, 2011. |
U.S. Appl. No. 12/223,080 / now U.S. Pat. No. 9,681,948, filed Jul. 16, 2014 / Jun. 20, 2017. |
U.S. Appl. No. 13/107,832 / now U.S. Pat. No. 8,235,933, filed May 13, 2011 / Aug. 7, 2012. |
U.S. Appl. No. 13/107,843 / now U.S. Pat. No. 8,328,751, filed May 13, 2011 / Dec. 11, 2012. |
U.S. Appl. No. 13/108,672 / now U.S. Pat. No. 9,724,499, filed May 16, 2011 / Aug. 8, 2017. |
U.S. Appl. No. 13/108,698, filed Jun. 16, 2011. |
U.S. Appl. No. 13/108,850, filed May 16, 2011. |
U.S. Appl. No. 13/108,880 / now U.S. Pat. No. 8,696,611, filed May 16, 2011 / Apr. 15, 2014. |
U.S. Appl. No. 13/193,309 / now U.S. Pat. No. 9,629,715, filed Jul. 28, 2011 / Apr. 25, 2017. |
U.S. Appl. No. 13/193,335 / now U.S. Pat. No. 9,034,034, filed Jul. 28, 2011 / May 19, 2015. |
U.S. Appl. No. 13/708,794 / now U.S. Pat. No. 9,943,670, filed Dec. 7, 2012 / Apr. 17, 2018. |
U.S. Appl. No. 14/154,080 / now U.S. Pat. No. 10,207,807, filed Jan. 13, 2014 / Feb. 19, 2019. |
U.S. Appl. No. 14/154,088, filed Jan. 13, 2014. |
U.S. Appl. No. 14/154,093, filed Jan. 13, 2014. |
U.S. Appl. No. 14/227,982 / now U.S. Pat. No. 9,707,382, filed Mar. 27, 2014 / Jul. 18, 2017. |
U.S. Appl. No. 14/282,615 / now U.S. Pat. No. 9,713,696, filed May 20, 2014 / Jul. 25, 2017. |
U.S. Appl. No. 14/712,801 / now U.S. Pat. No. 9,980,815, filed May 14, 2015 / May 29, 2018. |
U.S. Appl. No. 15/449,834 / now U.S. Pat. No. 10,076,403, filed Mar. 3, 2017 / Sep. 18, 2018. |
U.S. Appl. No. 15/492,852 / U.S. Pat. No. 10,368,981, filed Apr. 20, 2017 / Aug. 6, 2019. |
U.S. Appl. No. 15/570,752 / now U.S. Pat. No. 10,940,296, filed Oct. 31, 2017 / Mar. 9, 2021. |
U.S. Appl. No. 15/608,948, filed May 30, 2017. |
U.S. Appl. No. 15/624,314 / now U.S. Pat. No. 10,357,357, filed Jun. 15, 2017 / Jul. 23, 2019. |
U.S. Appl. No. 15/650,783 / now U.S. Pat. No. 10,639,459, filed Jul. 14, 2017 / May 5, 2020. |
U.S. Appl. No. 15/656,936 / now U.S. Pat. No. 10,478,594, filed Jul. 21, 2017 / Nov. 19, 2019. |
U.S. Appl. No. 15/668,622 / now U.S. Pat. No. 10,463,490, filed Aug. 3, 2017 / Nov. 5, 2019. |
U.S. Appl. No. 15/798,250, filed Oct. 30, 2017. |
U.S. Appl. No. 15/988,888 / now U.S. Pat. No. 10,828,151, filed May 24, 2018 / Nov. 10, 2020. |
U.S. Appl. No. 16/130,978 / now U.S. Pat. No. 10,251,740, filed Sep. 13, 2018 / Apr. 9, 2019. |
U.S. Appl. No. 16/130,988 / now U.S. Pat. No. 10,925,706, filed Sep. 13, 2018 / Feb. 23, 2021. |
U.S. Appl. No. 16/205,213 / now U.S. Pat. No. 10,835,394, filed Nov. 29, 2018 / Nov. 17, 2020. |
U.S. Appl. No. 16/374,698, filed Apr. 3, 2019. |
U.S. Appl. No. 16/395,209, filed Apr. 25, 2019. |
U.S. Appl. No. 16/408,419, filed May 9, 2019. |
U.S. Appl. No. 16/505,624, filed Jul. 8, 2019. |
U.S. Appl. No. 16/672,420, filed Nov. 1, 2019. |
U.S. Appl. No. 16/686,013, filed Nov. 15, 2019. |
U.S. Appl. No. 16/866,377, filed May 4, 2020. |
U.S. Appl. No. 16/875,652 / now U.S. Pat. No. 10,898,698, filed May 15, 2020 Jan. 26, 2021. |
U.S. Appl. No. 16/876,640, filed May 18, 2020. |
U.S. Appl. No. 16/878,228 / now U.S. Pat. No. 10,912,645, filed May 19, 2020 Feb. 9, 2021. |
U.S. Appl. No. 16/963,139, filed Jul. 17, 2020. |
U.S. Appl. No. 17/092,063, filed Nov. 6, 2020. |
U.S. Appl. No. 17/092,081, filed Nov. 6, 2020. |
U.S. Appl. No. 17/095,615, filed Nov. 11, 2020. |
U.S. Appl. No. 17/098,251, filed Nov. 13, 2020. |
U.S. Appl. No. 17/166,771, filed Feb. 3, 2021. |
U.S. Appl. No. 17/175,549, filed Feb. 12, 2021. |
Borlaug, et al., Latent Pulmonary Vascular Disease May Alter The Response to Therapeutic Atrial Shunt Device in Heart Failure, Circulation (Mar. 2022). |
Clowes, et al., Mechanisms of Arterial Graft Healing—Rapid Transmural Capillary Ingrowth Provides a Source of Intimal Endothelium and Smooth Muscle in Porous PTFE Prostheses, Am. J. Pathol., 123(2):220-230 (May 1986). |
Flachskampf, et al., Influence of Orifice Geometry and Flow Rate on Effective Valve Area: An In Vitro Study, Journal of the American College of Cardiology, 15(5):1173-1180 (Apr. 1990). |
Greitz, et al., Pulsatile Brain Movement and Associated Hydrodynamics Studied by Magnetic Resonance Phase Imaging, Diagnostic Neuroradiology, 34(5): 370-380 (1992). |
International Search Report & Written Opinion dated Feb. 3, 2023 in Int'l PCT Patent Appl. Serial No. PCT/IB2022/060621 (221001). |
International Search Report & Written Opinion dated Feb. 9, 2022 in Int'l PCT Patent Appl. Serial No. PCT/IB2021/060473 (201001). |
International Search Report & Written Opinion dated Mar. 29, 2023 in Int'l PCT Patent Appl. Serial No. PCT/IB2023/050743 (241001). |
International Search Report & Written Opinion dated May 17, 2022 in Int'l PCT Patent Appl. Serial No. PCT/IB2022/051177 (231001). |
International Search Report & Written Opinion dated Jul. 23, 2021 in Int'l PCT Patent Appl. Serial No. PCT/IB2021/053594 (191001). |
Pfeiffer, In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure, ESC Heart Failure, DOI: 10.1002/ehf2.14859 (May 22, 2024). |
Rodes-Cabau, et al., Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial, Eur. J. Heart. Fail., 26(4):1078-1089 (Apr. 2024). |
Shah, et al., Atrial Shunt Device For Heart Failure With Preserved And Mildly Reduced Ejection Fraction (Reduce LAP-HF II): A Randomised, Multicentre, Blinded, Sham-Controlled Trial, The Lancet, 399(10330):1130-1140 (Mar. 2022). |
Stone, Gregg, A Double-blind, Randomized Placebo-Procedure-Controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF: Principal Results from the RELIEVE-HF Trial, American College of Cardiology (ACC) (Apr. 6, 2024). |
Number | Date | Country | |
---|---|---|---|
20210187258 A1 | Jun 2021 | US |
Number | Date | Country | |
---|---|---|---|
62158022 | May 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15570752 | US | |
Child | 17192612 | US |